Pfizer’s Tikosyn Adds Contraindications, Warnings To Labeling
This article was originally published in The Pink Sheet Daily
Executive Summary
Revised labeling for the anti-arrhythmic moves a precaution on hypokalemia and potassium-depleting diuretics to the Warnings section. New labeling reflects a contraindication against “the concomitant use of hydrochlorothiazide (alone or in combinations such as with triamterene) with Tikosyn.”